|
⚲
|
| Keyboard |
| Schinazi Raymond F
✚
|
|
|---|---|
| CIK # | 0001397607 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001397607] | |
| 4 | [0001397607] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Precision Biosciences Inc | |
| Schinazi Raymond F | |
| Biozone Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Precision Biosciences Inc DTIL
Stock Option (Right to Buy) · derivative
|
2022-05-10 | Grant | 156,951 | $0.00 | |
|
Precision Biosciences Inc DTIL
Stock Option (Right to Buy) · derivative
|
2021-05-10 | Grant | 32,800 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2021-05-04 | Sell | 575,000 | $2.95 | 1,696,250 |
|
Precision Biosciences Inc DTIL
Stock Option (Right to Buy) · derivative
|
2020-05-13 | Grant | 41,038 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2019-10-25 | Buy | 7,906 | $1.15 | 9,092 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2019-10-24 | Buy | 5,094 | $1.15 | 5,858 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2019-10-23 | Buy | 3,935 | $1.04 | 4,092 |
|
Precision Biosciences Inc DTIL
Convertible Promissory Note · derivative
|
2019-04-01 | Conversion | 119,761 | ||
|
Precision Biosciences Inc DTIL
Series B Preferred Stock · derivative
|
2019-04-01 | Conversion | |||
|
Precision Biosciences Inc DTIL
Common Stock
|
2019-04-01 | Conversion | 36,946 | $13.60 | 502,466 |
|
Precision Biosciences Inc DTIL
Common Stock
|
2019-04-01 | Conversion | 56,102 | ||
|
Precision Biosciences Inc DTIL
Convertible Promissory Note · derivative
|
2019-03-27 | Other | $500,000.00 | ||
|
Precision Biosciences Inc DTIL
Stock Option (Right to Buy) · derivative
|
2019-03-27 | Grant | 34,544 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2018-09-21 | Grant | 50,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
8% Convertible Note · derivative
|
2018-05-10 | Disposed to issuer | 61,728 | $500,000.00 | 30,864,000,000 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2018-05-10 | Grant | 10,209 | $1.90 | 19,397 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2018-05-10 | Option exercise | 263,158 | $1.90 | 500,000 |
|
Biozone Pharmaceuticals Inc COCP
8% Convertible Note · derivative
|
2018-05-10 | Option exercise | 263,158 | $500,000.00 | 131,579,000,000 |
|
Biozone Pharmaceuticals Inc COCP
8% Convertible Note · derivative
|
2018-05-10 | Grant | 263,158 | $500,000.00 | 131,579,000,000 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2018-05-03 | Grant | 420,737 | $1.90 | 799,400 |
| showing 20 of 34 most recent transactions | |||||